This prospective study will examine eosinophils in various biological materials to compare the detection in those materials and ascertain the prognostic and predictive role of eosinophils in untreated non-small cell lung cancer patient.
Liège 4000, Belgium
o All stages of NSCLC
Stage III-IV NSCLC eligible for ICI treatment
18 years or older; non pregnant women
in stage III-IV: no previous ICI and before ICI (mono- or combination therapy) initiation
Signed informed consent
Clinical, biological and radiological evaluation at the CHU de Liège for at least 6 months following treatment initiation
Probable noncompliance with the follow-up requirements of the study (psychiatric condition, socio-economic factors)
Inclusion in a clinical study contraindicating the enrolment in the PROTEON study
Study Contact Info
Contact Listings Owner Form
PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC). 0 reviewsWrite Your Review
There are no reviews yet.